CombiMatrix

CombiMatrix Corporation, founded in 1995 and headquartered in Irvine, California, is a provider of clinical molecular diagnostic laboratory services in the United States. The company specializes in pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. CombiMatrix employs advanced technologies such as single nucleotide polymorphism, chromosomal microarray analysis, next-generation sequencing, fluorescent in situ hybridization, and high-resolution karyotyping to deliver its diagnostic services. These methods allow for the detection of genetic abnormalities that traditional methodologies may overlook, thereby enhancing patient care. CombiMatrix serves a diverse clientele, including commercial insurance companies, healthcare institutions, government payors, and individual patients. As of November 2017, CombiMatrix operates as a subsidiary of Invitae Corporation, continuing its commitment to advancing genetic diagnostics.